HistoSonics Expands Leadership Team as it Accelerates Growth

Dr. Josh Stopek Joins as Vice President of R&D; Dr. Jim Bertolina Named Chief Scientific Officer; Tom Tefft Appointed to Board of Directors ANN ARBOR, Mich., September 19, 2017 – HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, … Read More

HistoSonics Presents Preclinical Results at World Conference on Interventional Oncology (WCIO); Names MedTech Executives to Key Roles

ANN ARBOR, Mich. (June 7, 2017) — HistoSonics, Inc., a venture-backed medical device company developing a new image-guided, robotically assisted, platform therapy that is non-invasive and non-thermal, announced two significant developments today. Presentations at WCIO 2017 Researchers from the University … Read More

HistoSonics Appoints Mike Blue as CEO and Board Member; Completes First Close of a Series B Financing

ANN ARBOR, Mich. (March 13, 2017) — HistoSonics, Inc. announced today that Mike Blue has joined the Company as President, CEO and Board member to lead the advancement of HistoSonics’ innovative tissue-destruction technology in liver cancer and other solid tumor … Read More

VIDEO: Surgery without Knives or Needles

ANN ARBOR, Mich. (March 10, 2016) — See the University of Michigan’s video explaining histotripsy.

Click here to see the video

 

 

Tumor Ablation Expert Dr. Fred Lee, Jr. Joins HistoSonics as Board Member, Senior Medical Advisor

ANN ARBOR, Mich. (Sept. 16, 2016) — HistoSonics, Inc. announced today that noted radiologist and tumor ablation expert Fred Lee, Jr., MD, has joined the Company as Senior Medical Advisor and Board member to advance HistoSonics’ innovative tissue-destruction technology in liver … Read More